Amneal Pharmaceuticals Plunges 11.79% Amid Institutional Buying

On April 7, 2025, Amneal Pharmaceuticals, Inc. (AMRX) experienced a significant drop of 11.79% in pre-market trading, sparking concerns among investors and analysts alike.

One of the key factors contributing to the decline in Amneal's stock price is the recent increase in institutional holdings. Sei Investments Co. has raised its stake in Amneal Pharmaceuticals by 14.4% during the fourth quarter, which could indicate a shift in market sentiment or strategic investment decisions by major players.

Additionally, the market capitalization of Amneal Pharmaceuticals, which stands at $3.43 billion as of April 2025, places the company among the top 3,154 most valuable companies globally. This valuation, while substantial, may not fully reflect the current market dynamics and investor concerns, contributing to the recent stock price volatility.